Roy A, Roberts I, Norton A, Vyas P. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: A multi-step model of myeloid leukaemogenesis. Br J Haematol 2009;147(1):3-12.
DOI: 10.1111/j.1365-2141.2009.07789.x
Merino A. Diagnóstico diferencial de las leucemias agudas. In: Manual de Citología de Sangre Periférica y Líquidos Biológicos. 2.ª ed. Madrid: Editorial Médica Panamericana; 2020. p. 155-84.
Muramatsu H, Kato K, Watanabe N, Matsumoto K, Nakamura T, Horikoshi Y, et al. Risk factors for early death in neonates with Down syndrome and transient leukaemia. Br J Haematol 2008;142(4):6105.
DOI: 10.1111/j.1365-2141.2008.07231.x
Massey G V. Transient leukemia in newborns with Down syndrome. Pediatr Blood Cancer 2005;44(1):29-32.
DOI: 10.1002/pbc.20141
Watanabe K. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome. Pediatr Int 2019;61(3):222-9.
DOI: 10.1111/ped.13776